Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection
Biomolecules · 2024
DOI: 10.3390/biom14070847 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Dan He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Center, Medical Experiment Center, Shaanxi University of Chinese Medicine, Xianyang 712046, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Early Detection of Cancer, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Shaanxi University of Chinese Medicine Doctoral Start-up Funding., Scientific Research Program Funded by Education Department of Shaanxi Provincial Government, Shaanxi University of Chinese Medicine Doctoral Start-up Funding.
Abstract (Originalsprache)
Cancer poses a significant public health challenge worldwide, and timely screening has the potential to mitigate cancer progression and reduce mortality rates. Currently, early identification of most tumors relies on imaging techniques and tissue biopsies. However, the use of low-cost, highly sensitive, non-invasive detection methods for early cancer screening has become more attractive. Extracellular Vesicles (EVs) released by all living cells contain distinctive biological components, such as nucleic acids, proteins, and lipids. These vesicles play crucial roles in the tumor microenvironment and intercellular communication during tumor progression, rendering liquid biopsy a particularly suitable method for diagnosis. Nevertheless, challenges related to purification methods and validation of efficacy currently hinder its widespread clinical implementation. These limitations underscore the importance of refining isolation techniques and conducting comprehensive investigations on EVs. This study seeks to evaluate the potential of liquid biopsy utilizing blood-derived EVs as a practical, cost-effective, and secure approach for early cancer detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Animal Center, Medical Experiment Center, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
- Department of Experimental Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
- Department of Clinical Medicine of Second Clinical Medical School, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
- Basic Medical Academy, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
Förderung
- The Shaanxi University of Chinese Medicine Doctoral Start-up Funding.
- Scientific Research Program Funded by Education Department of Shaanxi Provincial Government
- Shaanxi University of Chinese Medicine Doctoral Start-up Funding
Zitieren
APA
He, D., Cui, B., Lv, H., Lu, S., Zhu, Y., Cheng, Y., Dang, L., & Zhang, H. (2024). Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection. Biomolecules. https://doi.org/10.3390/biom14070847
Vancouver
He D, Cui B, Lv H, Lu S, Zhu Y, Cheng Y, et al. Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection. Biomolecules. 2024. doi:10.3390/biom14070847
BibTeX
@article{He2024,
author = {He, Dan and Cui, Bozhou and Lv, Hongkai and Lu, Shuxian and Zhu, Yuan and Cheng, Yuqiang and Dang, Lin and Zhang, Hong},
title = {Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14070847}
}
EUVIMED